Wikidata

(Q81951210)

English

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

scientific article published on 10 September 2008

In more languages

Statements

title
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18784373
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18784373%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q81951210&oldid=1509255649"